Product image of Iomeron (Iomeprol) supplied by GNH India

Iomeron

Active Ingredient:
Iomeprol
Origin:
EU

Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injectable solution for intraarterial, intrathecal and intravenous use. It enhances X‑ray attenuation, allowing clearer visualization of vascular and tissue structures during imaging procedures. Iomeron is employed primarily in diagnostic radiology to improve image quality for patients undergoing contrast‑enhanced studies.

GNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Bracco Imaging France

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iomeron is used in radiographic imaging procedures that require enhanced contrast of vascular and tissue structures.

  • Angiography: provides high‑contrast visualization of blood vessels during X‑ray examinations.
  • Myelography: improves delineation of the spinal canal and nerve roots for diagnostic evaluation.
  • Computed tomography (CT) imaging: increases tissue differentiation, facilitating accurate diagnosis in contrast‑enhanced CT scans.

How It Works

  • Iomeprol contains high‑atomic‑number iodine atoms that absorb X‑ray photons more effectively than surrounding tissues. When administered intravenously, intra‑arterially, or intrathecally, the iodine increases X‑ray attenuation of blood vessels and extracellular spaces, creating a contrast difference that enhances the radiographic image of anatomical structures during angiography, myelography, and CT examinations.

Side Effects

Iomeron may cause a range of adverse reactions, from mild to severe, depending on patient sensitivity and clinical context.

Common Side Effects

  • Warm sensation or flushing at the injection site.
  • Nausea or mild vomiting.
  • Transient headache or dizziness.
  • Mild hypotension or feeling of light‑headedness.
  • Metallic taste in the mouth.
  • Mild injection‑site discomfort.

Serious or Rare Side Effects

  • Severe allergic reaction or anaphylaxis.
  • Acute renal toxicity, especially in patients with pre‑existing kidney impairment.
  • Persistent hypotension or cardiovascular collapse.
  • Cardiac arrhythmias.
  • Seizures or neurologic disturbances.
  • Life‑threatening bronchospasm.

Precautions & Warnings

Prior to administration, clinicians should evaluate patient-specific risk factors and follow appropriate safety measures.

  • Renal function assessment: verify adequate kidney function before use.
  • Allergy history: screen for prior reactions to iodinated contrast agents.
  • Thyroid disease: consider potential iodine load in patients with hyper‑ or hypothyroidism.
  • Hydration status: ensure adequate hydration to reduce nephrotoxic risk.
  • Pregnancy considerations: use only if clearly needed, as safety data are limited.
  • Store at ambient temperature: keep in original container, protect from moisture and direct light.

Avoid Interactions

Iomeron can interact with other medications, influencing safety or efficacy.

Major Interactions (Avoid)

  • Concurrent use of other iodinated contrast agents: increases total iodine load and risk of toxicity.
  • High‑dose nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): may exacerbate renal impairment.

Moderate Interactions (Monitor Closely)

  • Diuretics: may affect fluid balance and renal clearance.
  • Metformin: monitor for lactic acidosis in patients with reduced kidney function.
  • Beta‑blockers or ACE inhibitors: may influence blood pressure response during contrast administration.

Frequently Asked Questions

Iomeron is an iodinated contrast agent used to improve the visibility of blood vessels, spinal structures, and internal organs during angiography, myelography, and computed tomography (CT) imaging procedures. By enhancing X‑ray attenuation, it helps radiologists obtain clearer diagnostic images.

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When injected, the iodine increases the attenuation of X‑rays in the blood vessels and tissues it contacts, creating a contrast difference that makes anatomical structures appear more distinct on radiographic images.

The dose of Iomeron is determined by the prescribing clinician based on the specific imaging study, patient weight, renal function, and the required level of contrast enhancement. Healthcare providers calculate the appropriate volume and concentration for each individual case.

Safety data for Iomeron in pregnancy and lactation are limited. It should only be used when clearly necessary and after careful risk‑benefit assessment by the treating physician. Breastfeeding mothers should consult their healthcare provider regarding potential exposure.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Iomeron (Iomeprol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse reactions seen with some alternative contrast media.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperatures. Do not freeze or shake the vial before use.

Iomeron is administered as an injectable solution via intra‑arterial, intrathecal, or intravenous routes, depending on the imaging procedure. The administration is performed by qualified healthcare professionals under controlled conditions, typically using a power injector for precise delivery.

Serious risks include severe allergic reactions (anaphylaxis), acute renal toxicity, persistent hypotension, cardiac arrhythmias, and neurologic events such as seizures. Patients with known iodine allergy, compromised kidney function, or severe thyroid disease require careful assessment before use.

Iomeron should be avoided in patients with a documented severe allergy to iodinated contrast media, uncontrolled hyperthyroidism, severe renal impairment, or those who are pregnant unless the diagnostic benefit outweighs the potential risk. Clinicians must evaluate each patient’s medical history before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.